Literature DB >> 1958645

Smooth pursuit eye tracking dysfunction in schizophrenia: subcortical implications.

R T Pivik1.   

Abstract

The study of smooth pursuit eye tracking behavior in schizophrenics has occupied a prominent position in the search for biological correlates of this mental illness for nearly 20 years. During this time, impairments in this behavior have been shown to be a most robust finding in these patients. Attempts to further characterize the basis for this dysfunction have emphasized the role of cortical--particularly frontal--processes in both the symptomatology of schizophrenia and the eye tracking disturbance. In the present paper, arguments are made in support of a subcortical contribution to smooth pursuit eye tracking dysfunction in schizophrenia. Supporting data include new observations of cortical EEG variations in association with pursuit tracking disruptions, and a review of recent data indicating visual-vestibular and cerebellar-vestibular influences on the tracking disturbances in these patients. On the basis of such data, it is concluded that it is highly unlikely that a single mechanism or process is exclusively responsible for impaired pursuit tracking in schizophrenics, and that there are data to support both cortical and subcortical contributions to this dysfunction.

Entities:  

Mesh:

Year:  1991        PMID: 1958645      PMCID: PMC1188319     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  28 in total

1.  Effects of frontal eye field and superior colliculus ablations on eye movements.

Authors:  P H Schiller; S D True; J L Conway
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

2.  Eye-tracking performance and engagement of attention.

Authors:  C Shagass; R A Roemer; M Amadeo
Journal:  Arch Gen Psychiatry       Date:  1976-01

3.  Dark condition normalization of smooth pursuit tracking: evidence of cerebellar dysfunction in psychosis.

Authors:  R T Pivik; F W Bylsma; P M Cooper
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

4.  Dysfunction in a prefrontal substrate of sustained attention in schizophrenia.

Authors:  R M Cohen; W E Semple; M Gross; T E Nordahl; L E DeLisi; H H Holcomb; A C King; J M Morihisa; D Pickar
Journal:  Life Sci       Date:  1987-05-18       Impact factor: 5.037

5.  Eye tracking and psychopathology. New procedures applied to a sample of normal monozygotic twins.

Authors:  W G Iacono; D T Lykken
Journal:  Arch Gen Psychiatry       Date:  1979-11

Review 6.  Is eye movement dysfunction a biological marker for schizophrenia? A methodological review.

Authors:  B A Clementz; J A Sweeney
Journal:  Psychol Bull       Date:  1990-07       Impact factor: 17.737

7.  Eye-tracking patterns in schizophrenia.

Authors:  P S Holzman; L R Proctor; D W Hughes
Journal:  Science       Date:  1973-07-13       Impact factor: 47.728

8.  The effects of dark adaptation on pursuit tracking dysfunction in psychotics with impaired vestibular suppression.

Authors:  R T Pivik; F W Bylsma; P M Cooper
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1987       Impact factor: 5.067

9.  Recent studies of psychophysiology in schizophrenia.

Authors:  P S Holzman
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

10.  Caloric pattern test with special reference to failure of fixation-suppression.

Authors:  I Kato; Y Sato; M Aoyagi; K Mizukoshi; Y Kimura; Y Koike; N Hayano
Journal:  Acta Otolaryngol       Date:  1979       Impact factor: 1.494

View more
  2 in total

1.  Flexibility of foveal attention during ocular pursuit.

Authors:  Stephen J Heinen; Zhenlan Jin; Scott N J Watamaniuk
Journal:  J Vis       Date:  2011-02-10       Impact factor: 2.240

Review 2.  The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences.

Authors:  Hernàn Picard; Isabelle Amado; Sabine Mouchet-Mages; Jean-Pierre Olié; Marie-Odile Krebs
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.